Evaluation the value of markers for prediction of portal vein thrombosis after devascularization

Annals of Hepatology

Volumn 14, Issue 6, 2015, Pages 856-861

  Fei, Yang ^a   Zong, Guang quan ^a   Chen, Jian ^a   Liu, Ren min ^a  

^a The 81st Hospital of PLA   (China)

Author keywords

Combination; D dimer; P selectin

Indexed keywords

D DIMER; PADGEM PROTEIN; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; SELP PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DEVASCULARIZATION; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ADVERSE EFFECTS; AREA UNDER THE CURVE; BLOOD; COMPLICATION; DOPPLER ULTRASONOGRAPHY; ECHOGRAPHY; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MIDDLE AGED; PORTAL VEIN; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VASCULAR SURGERY; VENOUS THROMBOSIS;

ADULT; AREA UNDER CURVE; BIOMARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; P-SELECTIN; PORTAL VEIN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; VASCULAR SURGICAL PROCEDURES; VENOUS THROMBOSIS;

EID: 84943169284     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.5604/16652681.1171772     Document Type: Article

References (23)

1. Winslow ER, Brunt LM, Drebin JA. Portal vein thrombosis after splenectomy. Am J Surg 2002; 184: 631-5.
2. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis-new insights into aetiology and management. Aliment Pharmacol Ther 2005; 21: 1-9.
3. de Franchis R. Evolving consensus in portal hypertension. J Hepatol 2005; 43: 167-76.
4. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28: 868-80.
5. Garcia-Tsao G, Bosch J, Groszmann R. Portal hypertension and variceal bleeding, unresolved issues. Summary of an American Association for the study of liver disease and European Association for the study of the liver single-topic conference. Hepatology 2008; 47: 1764-72.
6. van der Bom JG, Heckbert SR, Lumley T, Holmes CE, Cushman M, Folsom AR, Rosendaal FR, et al. Platelet count and the risk for thrombosis and death in the elderly. J Thromb Haemost 2009; 7: 399-405.
7. Gosselin RC, Wu JR, Kottke-Marchant K, Peetz D, Christie DJ, Muth H, Panacek E. Evaluation of the Stratus CS Acute Care D-dimer assay (DDMR) using the Stratus CS STAT Fluorometric Analyzer: a prospective multisite study for exclusion of pulmonary embolism and deep vein thrombosis. Thromb Res 2012; 130: e274-e278.
8. Patel KN, Soubra SH, Bellera RV, Dong JF, McMullen CA, Burns AR, Rumbaut RE. Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia. Arterioscler Thromb Vasc Biol 2008; 28: 2225-30.
9. Smith K. Endoscopy: ESD is associated with a moderate risk of deep vein thrombosis that may be determined by Ddimer levels. Nat Rev Gastroenterol Hepatol 2011; 8: 538.
10. Gremmel T, Ay C, Seidinger D, Pabinger I, Panzer S, Koppensteiner R. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb. J Vasc Surg 2011; 54(6 Suppl.): 48S-55S.
11. Zong GQ, Fei Y, Chen J, Liu RM, Xu YF. Effects of selective double portazygous disconnection and devascularization on hemodynamics of the portal venous system. Med Ultrason 2014; 16: 291-7.
12. Zong GQ, Fei Y, Chen J, Liu RM. Selective double disconnection for cirrhotic portal hypertension. J Surg Res 2014; 192: 383-9.
13. Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol 2002; 97: 535-41.
14. Reit MV, Burger JW, van Muiswinkel JM. Diagnosis and treatment of portal vein thrombosis following splenectomy. Br J Surg 2000; 87: 1229-33.
15. Lisman T. Low molecular weight heparin in management and prevention of portal vein thrombosis. Thromb Res 2014; 134: 761-2.
16. Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol 2001; 66: 143-51.
17. Martin K, Kia L, Parikh-Neehar D, Kulik L, McMahon B. Heparin-induced thrombocytopenia testing is overutilized in cirrhosis & correlates with poor clinical outcomes. Ann Hepatol 2014; 13: 548-54.
18. Risch L, Monn A, Lüthy R, Honegger H, Huber AR. The predictive characteristics of D-dimer testing in outpatients with suspected venous thromboembolism: a Bayesian approach. Clin Chim Acta 2004; 345: 79-87.
19. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780-9.
20. Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 2010; 115: 481-8.
21. Ramacciotti E, Blackburn S, Hawley AE, Vandy F, Ballard-Lipka N, Stabler C, Baker N, et al. Evaluation of soluble Pselectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 2011; 17: 425-31.
22. Blann AD, Noteboom WM, Rosendaal FR. Increased soluble P-selectin levels following deep venous thrombosis: cause or effect. Br J Haematol 2000; 108: 191-3.
23. Myers DD, Hawley AE, Farris DM. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vase Surg 2003; 38: 1075-89.